Re-envisioning the supply chain to deliver transparent, game-changing value
Drivers for Change and Innovation
Traditional bulk purchasing of commercial clinical supply* is time consuming, inefficient, expensive and carries risk. Moreover, access to medicines, especially limited distribution drugs, has become increasingly complex and waste, overage or expired products continue to be a problem. Lastly, there has been an increase in the need for virtual or decentralized solutions as the industry continues to focus on patient-centric solutions.
SupplyRx Solutions
SupplyRx innovation eliminates conventional supply chain processes and waste, reduces costs and provides virtual, secure and efficient direct-to-patient solutions.
Bulk Purchasing
VS.
SupplyRx Innovation
Dispense to Patient*
Dispense to Patient*
* Commercial clinical supply = Any FDA (NDC) or Canadian (DIN) approved medicine or supply used in any phase study